Works matching AU VALENT, Peter

Results: 293
    1
    2
    3

    Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine.

    Published in:
    Journal of Innate Immunity, 2016, v. 8, n. 2, p. 111, doi. 10.1159/000443526
    By:
    • Valent, Peter;
    • Groner, Bernd;
    • Schumacher, Udo;
    • Superti-Furga, Giulio;
    • Busslinger, Meinrad;
    • Kralovics, Robert;
    • Zielinski, Christoph;
    • Penninger, Josef M.;
    • Kerjaschki, Dontscho;
    • Stingl, Georg;
    • Smolen, Josef S.;
    • Valenta, Rudolf;
    • Lassmann, Hans;
    • Kovar, Heinrich;
    • Jäger, Ulrich;
    • Kornek, Gabriela;
    • Müller, Markus;
    • Sörgel, Fritz
    Publication type:
    Article
    4
    5
    6
    7

    BRD4.

    Published in:
    Cell Cycle, 2014, v. 13, n. 5, p. 689, doi. 10.4161/cc.27859
    By:
    • Valent, Peter;
    • Zuber, Johannes
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15

    N‐terminal pro‐brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 290, doi. 10.1002/ajh.26805
    By:
    • Graf, Irene;
    • Greiner, Georg;
    • Marculescu, Rodrig;
    • Gleixner, Karoline V.;
    • Herndlhofer, Susanne;
    • Stefanzl, Gabriele;
    • Knoebl, Paul;
    • Jäger, Ulrich;
    • Hauswirth, Alexander;
    • Schwarzinger, Ilse;
    • Thalhammer, Renate;
    • Kundi, Michael;
    • Hoermann, Gregor;
    • Mitterbauer‐Hohendanner, Gerlinde;
    • Valent, Peter;
    • Sperr, Wolfgang R.
    Publication type:
    Article
    16

    BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemia.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1215, doi. 10.1002/ajh.26650
    By:
    • Peter, Barbara;
    • Eisenwort, Gregor;
    • Sadovnik, Irina;
    • Bauer, Karin;
    • Willmann, Michael;
    • Rülicke, Thomas;
    • Berger, Daniela;
    • Stefanzl, Gabriele;
    • Greiner, Georg;
    • Hoermann, Gregor;
    • Keller, Alexandra;
    • Wolf, Dominik;
    • Čulen, Martin;
    • Winter, Georg E.;
    • Hoffmann, Thomas;
    • Schiefer, Ana‐Iris;
    • Sperr, Wolfgang R.;
    • Zuber, Johannes;
    • Mayer, Jiří;
    • Valent, Peter
    Publication type:
    Article
    17

    PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 4, p. 390, doi. 10.1002/ajh.26461
    By:
    • Milosevic Feenstra, Jelena D.;
    • Jäger, Roland;
    • Schischlik, Fiorella;
    • Ivanov, Daniel;
    • Eisenwort, Gregor;
    • Rumi, Elisa;
    • Schuster, Michael;
    • Gisslinger, Bettina;
    • Machherndl‐Spandl, Sigrid;
    • Bettelheim, Peter;
    • Krauth, Maria‐Theresa;
    • Keil, Felix;
    • Bock, Christoph;
    • Cazzola, Mario;
    • Gisslinger, Heinz;
    • Kralovics, Robert;
    • Valent, Peter
    Publication type:
    Article
    18

    Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 10, p. E567, doi. 10.1002/ajh.24847
    By:
    • Sperr, Wolfgang R.;
    • Herndlhofer, Susanne;
    • Gleixner, Karoline;
    • Girschikofsky, Michael;
    • Weltermann, Ansgar;
    • Machherndl-Spandl, Sigrid;
    • Sliwa, Thamer;
    • Poehnl, Rainer;
    • Buxhofer-Ausch, Veronika;
    • Strecker, Karin;
    • Hoermann, Gregor;
    • Knoebl, Paul;
    • Jaeger, Ulrich;
    • Geissler, Klaus;
    • Kundi, Michael;
    • Valent, Peter
    Publication type:
    Article
    19
    20

    All systems red.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. 356, doi. 10.1002/ajh.23869
    By:
    • Karmacharya, Paras;
    • Donato, Anthony A;
    • Aryal, Madan Raj;
    • Pathak, Ranjan;
    • Goonewardene, Michael;
    • Valent, Peter
    Publication type:
    Article
    21
    22

    Monoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets.

    Published in:
    American Journal of Hematology, 2012, v. 87, n. 7, p. 721, doi. 10.1002/ajh.23214
    By:
    • Hauswirth, Alexander W.;
    • Almeida, Julia;
    • Nieto, Wendy G.;
    • Teodosio, Cristina;
    • Rodriguez-Caballero, Arancha;
    • Romero, Alfonso;
    • López, Antonio;
    • Fernandez-Navarro, Paulino;
    • Vega, Tomas;
    • Perez-Andres, Martin;
    • Valent, Peter;
    • Jäger, Ulrich;
    • Orfao, Alberto
    Publication type:
    Article
    23
    24
    25

    SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted.

    Published in:
    Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00468-7
    By:
    • Mancini, Manuela;
    • Monaldi, Cecilia;
    • De Santis, Sara;
    • Papayannidis, Cristina;
    • Rondoni, Michela;
    • Sartor, Chiara;
    • Bruno, Samantha;
    • Pagano, Livio;
    • Criscuolo, Marianna;
    • Zanotti, Roberta;
    • Bonifacio, Massimiliano;
    • Tosi, Patrizia;
    • Arock, Michel;
    • Valent, Peter;
    • Cavo, Michele;
    • Soverini, Simona
    Publication type:
    Article
    26
    27
    28
    29

    Metabolic drug survey highlights cancer cell dependencies and vulnerabilities.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27329-x
    By:
    • Pemovska, Tea;
    • Bigenzahn, Johannes W.;
    • Srndic, Ismet;
    • Lercher, Alexander;
    • Bergthaler, Andreas;
    • César-Razquin, Adrián;
    • Kartnig, Felix;
    • Kornauth, Christoph;
    • Valent, Peter;
    • Staber, Philipp B.;
    • Superti-Furga, Giulio
    Publication type:
    Article
    30
    31
    32

    Stable non-transforming minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia after autologous transplantation: origin from neoplastic yet ''pre-leukemic'' stem cells?

    Published in:
    Leukemia & Lymphoma, 2011, v. 52, n. 5, p. 842, doi. 10.3109/10428194.2011.557168
    By:
    • Böhm, Alexandra;
    • Herrmann, Harald;
    • Mitterbauer-Hohendanner, Gerlinde;
    • Hauswirth, Alexander W;
    • Rabitsch, Werner;
    • Mitterbauer, Margit;
    • Sperr, Wolfgang R;
    • Kalhs, Peter;
    • Jäger, Ulrich;
    • Valent, Peter
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.

    Published in:
    Leukemia & Lymphoma, 2006, v. 47, n. 3, p. 451, doi. 10.1080/10428190500353083
    By:
    • Wimazal, Friedrich;
    • Krauth, Maria-Theresa;
    • Vales, Anja;
    • Böhm, Alexandra;
    • Agis, Hermine;
    • Sonneck, Karoline;
    • Aichberger, Karl J.;
    • Mayerhofer, Matthias;
    • Simonitsch-Klupp, Ingrid;
    • Müllauer, Leonhard;
    • Sperr, Wolfgang R.;
    • Valent, Peter
    Publication type:
    Article
    43
    44
    45

    Mastocytosis: Pathology, genetics, and current options for therapy.

    Published in:
    Leukemia & Lymphoma, 2005, v. 46, n. 1, p. 35, doi. 10.1080/10428190400010775
    By:
    • Valent, Peter;
    • Akin, Cem;
    • Sperr, Wolfgang;
    • Mayerhofer, Matthias;
    • Födinger, Manuela;
    • Fritsche-Polanz, Robert;
    • Sotlar, Karl;
    • Escribano, Luis;
    • Arock, Michel;
    • Horny, Hans-Peter;
    • Metcalfe, Dean
    Publication type:
    Article
    46
    47
    48
    49
    50